BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36809781)

  • 21. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.
    Arber C; BitMansour A; Sparer TE; Higgins JP; Mocarski ES; Weissman IL; Shizuru JA; Brown JM
    Blood; 2003 Jul; 102(2):421-8. PubMed ID: 12663447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoselection techniques in hematopoietic stem cell transplantation.
    Li Pira G; Biagini S; Cicchetti E; Merli P; Brescia LP; Milano GM; Montanari M
    Transfus Apher Sci; 2016 Jun; 54(3):356-63. PubMed ID: 27209628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early myeloid-derived suppressor cells (HLA-DR
    Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
    Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
    J Immunol; 2011 Nov; 187(10):5130-40. PubMed ID: 22013117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.
    Shimoni A; Nagler A
    Cancer Treat Res; 2002; 110():113-36. PubMed ID: 11908195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
    Ishida T; Suzuki S; Lai CY; Yamazaki S; Kakuta S; Iwakura Y; Nojima M; Takeuchi Y; Higashihara M; Nakauchi H; Otsu M
    Stem Cells; 2017 Apr; 35(4):989-1002. PubMed ID: 27753160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study.
    Al-Homsi AS; Cole K; Bogema M; Duffner U; Williams S; Mageed A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1315-20. PubMed ID: 25765556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatio-Temporal Bone Remodeling after Hematopoietic Stem Cell Transplantation.
    Schwarz CS; Bucher CH; Schlundt C; Mertlitz S; Riesner K; Kalupa M; Verlaat L; Schmidt-Bleek O; Sass RA; Schmidt-Bleek K; Duda GN; Penack O; Na IK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo expansion of hematopoietic stem cells: mission accomplished?
    Takizawa H; Schanz U; Manz MG
    Swiss Med Wkly; 2011; 141():w13316. PubMed ID: 22252776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
    Törlén J; Gaballa A; Remberger M; Mörk LM; Sundberg B; Mattsson J; Uhlin M
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1260-1268. PubMed ID: 30710687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of hematopoietic stem cells heterogeneity for gene therapies.
    Epah J; Schäfer R
    Gene Ther; 2021 Sep; 28(9):528-541. PubMed ID: 33589780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopoietin-like protein 3 promotes preservation of stemness during ex vivo expansion of murine hematopoietic stem cells.
    Farahbakhshian E; Verstegen MM; Visser TP; Kheradmandkia S; Geerts D; Arshad S; Riaz N; Grosveld F; van Til NP; Meijerink JP
    PLoS One; 2014; 9(8):e105642. PubMed ID: 25170927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Wu X; Zhu K; Du X; Chen S; Yang L; Wu J; Liu Q; Li Y
    J Hematol Oncol; 2011 Apr; 4():19. PubMed ID: 21513557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.